🟢 Cerenome is trading 9.5% up in pre-market; no explaining announcement identified

Cerenome is trading 9.46% up at $1.79 in pre-market on October 8, with no new company announcement identified to explain the move.

• Cerenome closed at $1.64 on October 7.
• The latest company-specific news was an October 6 launch announcement for two CNSide molecular profiling tests, expected to become available October 12; coverage does not establish that this news drove the gain.
• Broader markets are weaker, so the provided context does not indicate a same-direction market explanation.